These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 6368590

  • 1. Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.
    Milne RW, Weech PK, Blanchette L, Davignon J, Alaupovic P, Marcel YL.
    J Clin Invest; 1984 Mar; 73(3):816-23. PubMed ID: 6368590
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS, Chait A, Hazzard WR.
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients.
    Marcoux C, Tremblay M, Nakajima K, Davignon J, Cohn JS.
    J Lipid Res; 1999 Apr; 40(4):636-47. PubMed ID: 10191287
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B.
    Vega GL, East C, Grundy SM.
    Atherosclerosis; 1988 Mar; 70(1-2):131-43. PubMed ID: 3162680
    [Abstract] [Full Text] [Related]

  • 12. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
    Rall SC, Weisgraber KH, Innerarity TL, Bersot TP, Mahley RW, Blum CB.
    J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects.
    Musliner TA, Giotas C, Krauss RM.
    Arteriosclerosis; 1986 Oct; 6(1):79-87. PubMed ID: 3942562
    [Abstract] [Full Text] [Related]

  • 16. Beta-VLDL accumulation in familial dysbetalipoproteinemia is associated with increased exchange or diffusion of chylomicron lipids to apo B-100 containing triglyceride-rich lipoproteins.
    Demacker PN, Bredie SJ, Vogelaar JM, Hectors MP, van Heijst P, Stuyt PM, Stalenhoef AF.
    Atherosclerosis; 1998 Jun; 138(2):301-12. PubMed ID: 9690913
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fish oil supplementation reduces beta-very low density lipoprotein in type III dysbetalipoproteinemia.
    Dallongeville J, Boulet L, Davignon J, Lussier-Cacan S.
    Arterioscler Thromb; 1991 Jun; 11(4):864-71. PubMed ID: 2065040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.